Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P3SH
|
|||
Former ID |
DIB004851
|
|||
Drug Name |
ReN-1826
|
|||
Synonyms |
Neurotrophin receptor program, Enact; Neurotrophin receptor program, ReNeuron
Click to Show/Hide
|
|||
Indication | Central nervous system disease [ICD-11: 8A04-8D87; ICD-10: G00-G99] | Terminated | [1] | |
Company |
University of Bristol
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Neurotrophin-3 (NTF3) | Target Info | Inhibitor | [2] |
Neurotrophin-4 (NTF4) | Target Info | Inhibitor | [2] | |
KEGG Pathway | MAPK signaling pathway | |||
Neurotrophin signaling pathway | ||||
NetPath Pathway | TNFalpha Signaling Pathway | |||
Pathway Interaction Database | SHP2 signaling | |||
p75(NTR)-mediated signaling | ||||
Neurotrophic factor-mediated Trk receptor signaling | ||||
Trk receptor signaling mediated by the MAPK pathway | ||||
WikiPathways | MAPK Signaling Pathway | |||
Differentiation Pathway | ||||
BDNF signaling pathway | ||||
Integrated Pancreatic Cancer Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017722) | |||
REF 2 | Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J Allergy Clin Immunol. 2006 Sep;118(3):597-605. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.